Archive for December, 2010

December 28th, 2010

Looking Forward to 2011

CardioExchange invited a wide range of members−researchers, teachers, private practice clinicians, and fellows−to offer predictions for 2011. We summarize their lists here and offer a running scorecard. Click the authors’ names to read the full posts. The same CardioExchange members give us their impressions of the most important developments in cardiology in 2010, and you […]


December 24th, 2010

A Look Back at 2010

CardioExchange invited a wide range of members−researchers, teachers, private practice clinicians, and fellows−to give us their impressions of the most important developments in cardiology in 2010. We summarize their lists here and offer a running scorecard. Click the authors’ names to read the full posts.  The same CardioExchange members offered predictions for 2011, and you […]


December 23rd, 2010

Thad Waites: Looking Back at 2010 and Ahead to 2011

To celebrate the holiday season, CardioExchange asked several of our contributors to choose the 3 most important cardiology-related events of the past year and to make 3 predictions for 2011. Looking back at 2010: 1. Dabigatran, which has been released, and the other oral thrombin inhibitors, which will be released: Imagine, we finally have  a replacement for warfarin, […]


December 23rd, 2010

James De Lemos: Looking Back at 2010 and Ahead to 2011

To celebrate the holiday season, CardioExchange asked several of our contributors to choose the 3 most important cardiology-related events of the past year and to make 3 predictions for 2011. Looking back at 2010: ACGME releases new work hour rules. Although these new guidelines are not specifically focused on cardiology training, they promise to impact all […]


December 23rd, 2010

Barry Massie: Looking Back at the Year in Heart Failure

To celebrate the holiday season, CardioExchange asked several of our contributors to choose the most important cardiology-related events of the past year. Barry Massie has focused on heart failure, providing us with his choice of the four most important stories of 2010. 1. Aldosterone antagonists continue their winning streak: Following the convincing reductions in mortality and morbidity […]


December 23rd, 2010

John Brush: Looking Back at 2010 and Ahead to 2011

To celebrate the holiday season, CardioExchange asked several of our contributors to choose the 3 most important cardiology-related events of the past year and to make 3 predictions for 2011. Looking back at 2010: 1. The PARTNER Trial demonstrated the efficacy of transcatheter aortic valve implantation for patients deemed too high risk for conventional cardiac surgery.  […]


December 23rd, 2010

John Mandrola: Looking Back at 2010 and Ahead to 2011

To celebrate the holiday season, CardioExchange asked several of our contributors to choose the 3 most important cardiology-related events of the past year and to make 3 predictions for 2011. Looking back at 2010: 1. By far, the number one heart story of 2010 was the release of the novel blood-thinning drug, dabigatran (Pradaxa), for the prevention […]


December 22nd, 2010

Apixaban Beats Enoxaparin for Thromboprophylaxis After Hip Replacement

In the ADVANCE-3 trial 5,407 hip replacement patients were randomized to receive thromboprophylaxis with either the new oral factor Xa inhibitor apixaban or enoxaparin. The rate of DVT, nonfatal PE, or death from any cause was 1.4% in the apixaban group compared to 3.9% in the enoxaparin group (RR 0.36, CI 0.22-0.54, P<0.001), thereby demonstrating […]


December 22nd, 2010

John Ryan: Looking Back at 2010 and Ahead to 2011

To celebrate the holiday season, CardioExchange asked several of our contributors to choose the 3 most important cardiology-related events of the past year and to make 3 predictions for 2011. Looking back at 2010: 1. Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment: Ten years after the initial decoding of the human genome, we felt […]


December 22nd, 2010

Deepak Bhatt: Looking Back at 2010 and Ahead to 2011

To celebrate the holiday season, CardioExchange asked several of our contributors to choose the 3 most important cardiology-related events of the past year and to make 3 predictions for 2011. Looking back at 2010: 1. PARTNER: Transcatheter aortic valve implantation significantly improved symptoms and reduced mortality in patients with severe aortic stenosis who were not candidates […]